Co-Founder, Board Chair
CurrentManas AI leverages proprietary AI, generative computational chemistry, and best in class biology to cut the timeline and costs of traditional therapeutic discovery and transform the treatment of cancer and rare disease. While we're still in the early stages of contemporary AI development, initiatives like Manas AI show how close we already are to advances that can profoundly change the world. Success in our quest will give thousands of oncologists around the world new therapeutics to combat diseases that have shaped human existence since before recorded history, constraining human possibilities and causing immense suffering and loss. The future of medicine has never held more promise.